BioCND, a local biopharmaceutical pharmaceutical, said Thursday it has signed an agreement with Chinese biopharmaceutical company Genor Biopharma to cooperate in the biosimilar sector.
Under the deal with the Shanghai-based company, BioCND said both companies will take charge of developing, testing and manufacturing two biosimilar products, Humira and Herceptin, the company said in a press r...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.